Most Read News

Alembic’s version is a generic substitute for Tegretol-XR, a medicine originally developed by Novartis.

The deal spans five and a half years and involves the supply of regasification services for roughly 25.6 trillion British thermal units (TBTUs) of LNG annually.

The capital was infused via cash and will be used to support DRL Russia’s working capital requirements.

As of June 30, the company’s net debt stood at ₹4,972 crore. This figure does not include ₹760 crore in lease liabilities.

The previous tenure of the committee was scheduled to end on July 28.

SAIL reported EBITDA of ₹2,767 crore for the quarter, marking a 24.7% increase from ₹2,219 crore in the corresponding period last year.

WABAG will be in charge of designing and constructing the plants, as well as managing them for a decade after they’re commissioned.

The project will be executed at BEL’s Palasamudram unit in Andhra Pradesh and is expected to be completed over 24 months.

A quick look at the six key global and domestic signals over the last one week

The net interest margin, however, declined. At 3.72%, it was lower than the 3.86% recorded in the March quarter.